Nissan Medical Industries Ltd reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was ILS 176.47 million compared to ILS 166.19 million a year ago. Net income was ILS 0.467 million compared to net loss of ILS 25.8 million a year ago. Basic earnings per share from continuing operations was ILS 0.05 compared to basic loss per share from continuing operations of ILS 2.78 a year ago. Diluted earnings per share from continuing operations was ILS 0.05 compared to diluted loss per share from continuing operations of ILS 2.78 a year ago.
For the nine months, sales was ILS 541.57 million compared to ILS 504.32 million a year ago. Net loss was ILS 1.71 million compared to ILS 28.95 million a year ago. Basic loss per share from continuing operations was ILS 0.19 compared to ILS 3.11 a year ago. Diluted loss per share from continuing operations was ILS 0.19 compared to ILS 3.11 a year ago.